Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Empyema, Thoracic

voriconazole has been researched along with Empyema, Thoracic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Chang, KM; Donaghy, HJ; Jurado, JE; Kim, AC1
Koff, A; Malinis, M1
Chiu, I; Fuller, J; Remington, TL1
Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I1
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T1
Caliandro, R; Girard, P; Stern, JB1

Reviews

1 review(s) available for voriconazole and Empyema, Thoracic

ArticleYear
Aspergillus pleural empyema in a chronic smoker - A case report and review of literature.
    Journal de mycologie medicale, 2022, Volume: 32, Issue:4

    Topics: Aspergillosis; Aspergillus; Empyema, Pleural; Humans; Male; Smokers; Voriconazole

2022

Other Studies

5 other study(ies) available for voriconazole and Empyema, Thoracic

ArticleYear
Chest Pain and a Cavitary Lung Mass in a Woman With Diabetes.
    JAMA, 2020, Jun-16, Volume: 323, Issue:23

    Topics: Antifungal Agents; Aspergillus niger; Chest Pain; Diabetes Mellitus, Type 2; Empyema, Pleural; Female; Hemoglobin A; Humans; Middle Aged; Piperacillin, Tazobactam Drug Combination; Streptococcus agalactiae; Tomography, X-Ray Computed; Vancomycin; Voriconazole

2020
Chronic necrotizing pulmonary aspergillosis in a patient with diabetes and marijuana use.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015, Nov-17, Volume: 187, Issue:17

    Topics: Adult; Antifungal Agents; Cannabis; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Empyema, Pleural; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Marijuana Smoking; Medical Marijuana; Pneumothorax; Radiography; Volatilization; Voriconazole

2015
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
    Mycoses, 2010, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:3

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diffusion; Empyema, Pleural; Humans; Male; Pleura; Pyrimidines; Triazoles; Voriconazole

2004